Showing results (81-90 of 1,138) with videos related to
Sort By:
Pageof 114
Current Drug Safety|April 22, 2010
Restless leg syndrome associated with olanzapine: a case seriesShilpa Aggarwal, Seetald Dodd, Michael BerkAnti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|May 9, 2013
N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trialAhmad Ghanizadeh, Nima Derakhshan, Michael BerkCurrent Reviews in Clinical and Experimental Pharmacology|May 6, 2024
Current Pharmacotherapies for Smoking Cessation and Promising Emerging DrugsSeetal Dodd, Jodie Harper, Michael BerkJAMA Psychiatry|June 4, 2020
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical TrialMichael Berk, Robyn L Woods, Mark R Nelson, et al.Molecular Psychiatry|January 28, 2021
Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trialMichael Berk, Bruno Agustini, Robyn L Woods, et al.Harvard Review of Psychiatry|May 5, 2016
Integrating Early Intervention for Borderline Personality Disorder and Mood DisordersAndrew M Chanen, Michael Berk, Katherine ThompsonThe Australian and New Zealand Journal of Psychiatry|February 16, 2006
Pharmacological treatment in the early phase of bipolar disorders: what stage are we at?Philippe Conus, Michael Berk, Patrick D McGorryThe Australian and New Zealand Journal of Psychiatry|December 17, 2009
Is lithium in a class of its own? A brief profile of its clinical useGin S Malhi, Danielle Adams, Michael BerkProgress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 2011
Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidenceDavid A Camfield, Jerome Sarris, Michael BerkThe Medical Journal of Australia|August 18, 2010
The pharmacological treatment of bipolar disorder in primary careGin S Malhi, Danielle Adams, Michael BerkPageof 114